Humacyte, Inc.
HUMA
$1.41
$0.021.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.65% | 72.54% | 75.82% | 58.00% | 26.52% |
| Total Depreciation and Amortization | 1.00% | 2.16% | 2.08% | 1.09% | -2.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 114.77% | -211.79% | -218.73% | -202.26% | -273.14% |
| Change in Net Operating Assets | -229.54% | -7,622.51% | -395.88% | -204.90% | -321.88% |
| Cash from Operations | -2.18% | -7.05% | -16.44% | -29.49% | -21.17% |
| Capital Expenditure | 41.02% | 43.77% | 45.27% | -47.21% | 7.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 41.02% | 43.77% | 45.27% | -47.21% | -339.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 20.69% | -8.53% | -13.47% | -13.85% | 92.20% |
| Issuance of Common Stock | -11.90% | 16.50% | 143.80% | 133.17% | 131.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14,480.16% | -558.68% | -351.91% | -101.78% | -101.05% |
| Cash from Financing | -61.21% | -46.15% | -11.97% | 64.56% | 44.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,319.41% | -406.72% | -73.66% | 73.26% | 80.62% |